STAT1 promotes radioresistance of CD44+/CD242-/low cells in breast cancer

Experimental Biology and Medicine

Volumn 236, Issue 4, 2011, Pages 418-422

  Zhan, Jun Fang ^a   Chen, Long Hua ^a   Yuan, Ya Wei ^a   Xie, Guo Zhu ^a   Sun, Ai Min ^a   Liu, Ying ^a   Chen, Zhi Xian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cancer initiating cells; Radioresistance; STAT1

Indexed keywords

CD24 ANTIGEN; FLUDARABINE; HERMES ANTIGEN; MESSENGER RNA; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL ISOLATION; CELL SURVIVAL; CLONOGENIC ASSAY; COLONY FORMING CELL; CONTROLLED STUDY; DRUG TARGETING; IRRADIATION; MAMMOSPHERE; MONOLAYER CULTURE; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BREAST TUMOR; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; TUMOR CELL LINE;

ANTIGENS, CD24; ANTIGENS, CD44; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; RADIATION TOLERANCE; STAT1 TRANSCRIPTION FACTOR;

EID: 79958786755     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010287     Document Type: Article

References (11)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-988
2. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506-5511
3. Klampfer L. Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 2006;6:107-21
4. Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 2004;101:1714-1719
5. Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X, Zhu JX, Gao Y, Mai W, Furge K, Qian CN, Amato R, Butler EB, Teh BT, Teh BS. Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Int J Radiat Oncol Biol Phys 2009;73:288-295.
6. Efimova EV, Liang H, Pitroda SP, Labay E, Darga TE, Levina V, Lokshin A, Roizman B, Weichselbaum RR, Khodarev NN. Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol 2009;85:421-431
7. Pitroda SP, Wakim BT, Sood RF, Beveridge MG, Beckett MA, MacDermed DM, Weichselbaum RR, Khodarev NN. STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect. BMC Med 2009;7:68
8. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111
9. Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 2006;98:1755-1757
10. Phillips TM, McBride WH, Pajonk F. The response of CD24(2/low)/CD44{thorn} breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777-1785
11. Tsai SY, Hsieh TC, Ardelt B, Darzynkiewicz Z, Wu JM. Combined effects of onconase and IFN-beta on proliferation, macromolecular syntheses and expression of STAT-1 in JCA-1 cancer cells. Int J Oncol 2002;20:891-896